Spironolactone 25mg
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Oregon Health and Science University
Overview
Spironolactone 25mg is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Spironolactone 25mg clinical trials
Explore related
Medical disclaimer. This page summarizes research about Spironolactone 25mg for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.